Chemical Structure : ADT-030
货号: PC-26071Not For Human Use, Lab Use Only.
ADT-030 is a potent, selective Phosphodiesterase 10 (PDE10) inhibitor, inhibits enzymatic activity of recombinant PDE10 using cAMP and cGMP as substrates with IC50 of 0.95 uM and 1.15 uM respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ADT-030 is a potent, selective Phosphodiesterase 10 (PDE10) inhibitor, inhibits enzymatic activity of recombinant PDE10 using cAMP and cGMP as substrates with IC50 of 0.95 uM and 1.15 uM respectively.
ADT-030 inhibits the proliferation of a series of KRAS G12D and KRAS G12C mutant PDAC cell lines with IC50 values in the low micromolar range (1.8-4.5 uM).
ADT-030 selectively inhibits the proliferation of KRAS mutant PDAC cells, but not KRAS wild-type PDAC cell line BxPC-3.
ADT-030 inhibits the proliferation, colony formation, and motility of PDAC cell lines harboring KRASG12D and KRASG12C mutations.
ADT-030 induces apoptosis and G2/M cell cycle arrest in PDAC cells.
ADT-030 blocks PDE10 and activates PKA/PKG to reduce β-catenin levels and inhibit RAS signaling.
ADT-030 also inhibits the growth of KRASG12D and KRASG12C mutant PDAC cells resistant to allele-specific KRAS inhibitors.
ADT-030 significantly suppressed tumor growth, reduced lung and liver metastasis, and increased survival without systemic toxicity in syngeneic and patient-derived xenograft (PDX) PDAC models.
| 分子量 | 478.59 | |
| 分子式 | C28H34N2O5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Reddy Bandi DS, et al. bioRxiv [Preprint]. 2026 Feb 13:2026.02.11.705411.
2. Patent WO2016100542 A1.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright